Police & Firemen s Retirement System of New Jersey lifted its stake in shares of Humana Inc. (NYSE:HUM – Free Report) by 4.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,304 shares of the insurance provider’s stock after purchasing an additional 790 shares during the quarter. Police & Firemen s Retirement System of New Jersey’s holdings in Humana were worth $4,475,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. raised its position in Humana by 8.9% during the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock worth $3,697,222,000 after buying an additional 1,143,662 shares during the last quarter. Dodge & Cox raised its holdings in Humana by 5.5% during the first quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider’s stock worth $2,845,830,000 after purchasing an additional 557,175 shares in the last quarter. Pzena Investment Management LLC lifted its position in Humana by 6.5% in the second quarter. Pzena Investment Management LLC now owns 4,076,667 shares of the insurance provider’s stock valued at $996,664,000 after purchasing an additional 247,744 shares during the period. Geode Capital Management LLC boosted its holdings in Humana by 1.9% in the 2nd quarter. Geode Capital Management LLC now owns 3,130,829 shares of the insurance provider’s stock valued at $762,233,000 after purchasing an additional 57,267 shares in the last quarter. Finally, Davis Selected Advisers increased its position in Humana by 3.3% during the 1st quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider’s stock worth $616,873,000 after purchasing an additional 74,434 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
HUM has been the subject of several recent analyst reports. Truist Financial reduced their price target on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a report on Monday, November 10th. Sanford C. Bernstein increased their price objective on Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Bank of America raised their target price on Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a report on Friday, October 10th. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a research report on Wednesday, October 8th. Finally, Piper Sandler cut their price target on shares of Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a report on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $298.39.
Humana Price Performance
Shares of NYSE HUM opened at $236.94 on Friday. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The company’s 50-day moving average price is $271.04 and its 200 day moving average price is $258.04. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The stock has a market cap of $28.50 billion, a price-to-earnings ratio of 18.18, a PEG ratio of 1.71 and a beta of 0.42.
Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. During the same quarter in the previous year, the business posted $4.16 earnings per share. The firm’s quarterly revenue was up 11.1% compared to the same quarter last year. As a group, research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.
Humana Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio is 33.18%.
Humana Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Stories
- Five stocks we like better than Humana
- 3 Best Fintech Stocks for a Portfolio Boost
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- Differences Between Momentum Investing and Long Term Investing
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
